Reference priceKRW ₩607,424.02Original source price: INR 37,495.31. Converted estimates are available by currency selection.
| Brand | Zydus Cadila |
|---|---|
| Manufacturer | ZYDUS CADILA |
| Prescription required | Yes |
Ujvira 100mg Injection
TRASTUZUMAB EMTANSINE (100MG)
Description
Ujvira 100mg Injection is a targeted therapy containing the active constituent trastuzumab emtansine. The U.S. Food and Drug Administration (FDA) approved trastuzumab emtansine on February 22, 2013, for treating patients with HER2-positive metastatic breast cancer who have previously received trastuzumab and chemotherapy. This medication is not recommended for adolescents and children under 18. Before taking this medicine, it is vital to inform your doctor if you have any blood clot disorders, liver disorders, or allergies.Benefits
Ujvira 100mg Injection is indicated for its use in the following conditions: Advanced and metastatic breast cancerHow to Use
1.Ujvira 100mg Injection shall either be administered before or after surgery. 2. It will be given as an Intravenous infusion for 90 minutes, if well tolerated it shall be administered within 30 minutes for the next doses.Specification
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious Heart Problems Allergic reactions Kidney problems Breathing difficultiesThis information is for reference only. Consult a qualified healthcare professional before using any medicine.